Login
$MRNA
$214.08 After hours

$MRNA SEC Filings

Filed On Filing
16 Nov 2026 144
13 Nov 2026 8-K: Departure/Election of Directors or Officers; Compensation
09 Nov 2026 Form 4: Andres Juan, Chief Operating Officer

Granted 7,898 Stock Option (Right to Buy) · Granted 16,955 Restricted Stock Units

06 Nov 2026 10-Q
06 Nov 2026 8-K: Results of Operations and Financial Condition

Reports third quarter revenue of $1.3 billion, GAAP net income of $0.2 billion and GAAP diluted EPS of $0.38

05 Nov 2026 SCHEDULE 13G/A
16 Oct 2026 Form 4: Hoge Stephen, President

Received 76,453 shares by exercise or conversion ($933K) · Sold 39,224 shares ($8.37M) · Received 76,452 shares by exercise or conversion ($933K) · 1 more

15 Oct 2026 144
14 Oct 2026 144
07 Oct 2026 Form 4: Mock James M, Chief Financial Officer

Received 1,454 shares by exercise or conversion · Gave up 704 shares to cover exercise price or tax ($134K)

05 Oct 2026 Form 3: Andres Juan, Chief Operating Officer

Holds 125,000 shares of Common Stock

30 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Jerh Collins to Retire Following Four Years of Leadership at Moderna

16 Sep 2026 Form 4: Hoge Stephen, President

Received 76,453 shares by exercise or conversion ($933K) · Sold 40,294 shares ($5.81M) · Received 76,452 shares by exercise or conversion ($933K) · 1 more

15 Sep 2026 144
14 Sep 2026 Form 4: Mock James M, Chief Financial Officer

Received 19,836 shares by exercise or conversion ($614K) · Sold 34,836 shares ($4.69M)

14 Sep 2026 144
10 Sep 2026 144
08 Sep 2026 Form 4: Mock James M, Chief Financial Officer

Received 11,797 shares by exercise or conversion · Gave up 5,704 shares to cover exercise price or tax ($849K)

08 Sep 2026 Form 4: Klinger Shannon Thyme, Chief Legal Officer

Received 11,797 shares by exercise or conversion · Gave up 5,704 shares to cover exercise price or tax ($849K)

03 Sep 2026 Form 4: Klinger Shannon Thyme, Chief Legal Officer

Received 5,637 shares by exercise or conversion · Sold 3,471 shares ($486K) · Gave up 1,048 shares to cover exercise price or tax ($147K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support